Physician

Raymond J Dean, MD

According to 2025 Medicare claims, Raymond Dean, MD (NPI: 1023033255) practices dermatology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is ASSOCIATES IN DERMATOLOGY OF TRAVERSE CITY PC (NPI: 1861430779; TIN: 383526691) and primary practice location at 49684-7760. Dean is affiliated with the Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

Dean's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 892 traditional Medicare patients, billed 3,858 HCPCS/CPT codes, and received $147,930 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 887 prescription claims across 452 beneficiaries totaling $524,096 in drug costs, led by Humira Pen (Adalimumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $238,944 to $147,930. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $285,331 to $524,096. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$119K$239K2015 Medicare payment: $238,944 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $219,245 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $177,871 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $214,869 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $198,297 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $154,327 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $170,043 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $159,929 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $142,323 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $147,930 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4837,105$238,944
20161,3707,017$219,245
20171,1205,883$177,871
20181,3086,878$214,869
20191,2016,264$198,297
20209634,571$154,327
20219424,406$170,043
20229224,228$159,929
20238913,696$142,323
20248923,858$147,930

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$298K$597K2015 Drug cost: $285,331 (USD; Tot_Drug_Cst)2016 Drug cost: $596,597 (USD; Tot_Drug_Cst)2017 Drug cost: $590,533 (USD; Tot_Drug_Cst)2018 Drug cost: $464,080 (USD; Tot_Drug_Cst)2019 Drug cost: $436,902 (USD; Tot_Drug_Cst)2020 Drug cost: $296,108 (USD; Tot_Drug_Cst)2021 Drug cost: $297,888 (USD; Tot_Drug_Cst)2022 Drug cost: $328,436 (USD; Tot_Drug_Cst)2023 Drug cost: $312,599 (USD; Tot_Drug_Cst)2024 Drug cost: $524,096 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015374720$285,331
2016425873$596,597
2017396787$590,533
2018438911$464,080
2019407851$436,902
2020394755$296,108
2021400787$297,888
2022404806$328,436
2023441829$312,599
2024452887$524,096

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths8394$71
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more107107$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more751978$60
17000Destruction of precancer skin growth, 1 growth483620$42
17003Destruction of precancer skin growth, 2-14 growths3491,628$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab30843$205,401
Cosentyx Sensoready (2 Pens)Secukinumab12336$88,874
FluorouracilFluorouracil1173,828$6,971
MetronidazoleMetronidazole702,425$3,451
CalcipotrieneCalcipotriene20715$2,787

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Raymond J. Dean, MD?

Tedicare shows public-source Medicare data for Raymond J. Dean, MD (NPI 1023033255), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raymond J. Dean, MD have ACO affiliation data?

Raymond J. Dean, MD is shown with ACO affiliation data for Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to Raymond J. Dean, MD?

Raymond J. Dean, MD is linked to ASSOCIATES IN DERMATOLOGY OF TRAVERSE CITY PC (billing NPI 1861430779) in the available physician profile data.

Does Raymond J. Dean, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.